Identification of the Stages of Diabetic Nephropathy at Which Angiotensin II Receptor Blockers Most Effectively Suppress Albuminuria
Author:
Publisher
Oxford University Press (OUP)
Subject
Internal Medicine
Link
http://academic.oup.com/ajh/article-pdf/26/9/1064/17460213/hpt085.pdf
Reference25 articles.
1. Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy;Hypertens Res,2007
2. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect;MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators;Circulation,2002
3. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes;INNOVATION Study Group;Diabetes Care,2007
4. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol;LIFE Study Group;Lancet,2002
5. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy;Hypertension,2006
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical efficacy and safety of Tripterygium wilfordii Hook in the treatment of diabetic kidney disease stage IV;Medicine;2019-03
2. Independent regulation of renin–angiotensin–aldosterone system in the kidney;Clinical and Experimental Nephrology;2018-03-29
3. Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients;International Journal of Molecular Sciences;2016-10-27
4. Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes;Journal of Diabetes Research;2015
5. Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes;BMJ OPEN DIAB RES CA;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3